{"nct_id":"NCT03559517","title":"Efficacy and Safety Study of Ontamalimab as Induction Therapy in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 305)","status":"TERMINATED","status_verified_date":"2021-04","start_date":"2018-08-29","start_date_type":"ACTUAL","primary_completion_date":"2020-07-07","primary_completion_date_type":"ACTUAL","completion_date":"2020-10-08","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["TAK"]}